Pharmacyclics? Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD
Pharmacyclics LLC today announced interim results from the ongoing Phase Ib/II PCYC-1129 study suggesting that ibrutinib (IMBRUVICA) may be a safe and effective treatment for patients with...
